{"id":13111,"date":"2025-04-24T18:04:01","date_gmt":"2025-04-24T12:34:01","guid":{"rendered":"https:\/\/gwcindia.in\/blog\/?p=13111"},"modified":"2025-04-24T18:04:30","modified_gmt":"2025-04-24T12:34:30","slug":"market-overview-3","status":"publish","type":"post","link":"https:\/\/www.gwcindia.in\/blog\/market-overview-3\/","title":{"rendered":"MARKET OVERVIEW :"},"content":{"rendered":"
Nifty 50 opened today’s trade session 1,999.45 points away from its record high of 26,277.35.<\/strong> Markets today are reacting to LTIMindtree, Bajaj Housing Finance, Dalmia Bharati earnings.<\/strong><\/p>\n HUL, L&T Tech, Axis Bank, Persistent Systems, Tech Mahindra, Nestle India, Mphasis, Laurus Labs, ACC, SBI Card, are among the companies reporting their quarterly earnings today.<\/strong><\/p>\n Biocon, 360 ONE WAM, Can Fin Homes, Tamilnad Mercantile Bank, Spandana Sphoorty, Supreme Petrochem, Dalmia Bharat, Rallis India, Syngene International, GNA Axles are among the other stocks in focus today.<\/strong><\/p>\n \u00a0<\/strong><\/p>\n The buzz around GLP-1 drugs \u2014 used for treating diabetes and now increasingly associated with weight loss \u2014 has sparked investor interest in Indian pharma manufacturers.<\/strong><\/p>\n FMCG giant\u00a0Hindustan Unilever Ltd. reported results for the January-March period on Thursday, April 24, which were in-line with analyst expectations. The stock is up 1.5% in trading after the results announcement.<\/strong><\/p>\n The Mumbai-based company reported revenue of \u20b915,213 crore during the March quarter, which was 2.4% higher compared to the same quarter last year. A CNBC-TV18 poll had projected HUL’s revenue to grow by 2% during<\/strong><\/p>\n HUL’s Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) increased by 1% during the March quarter to \u20b93,466 crore. The figure is marginally lower with the consensus estimates of analysts, which pegged the figure to be \u20b93,505 crore.<\/strong> Net profit for the period stood at \u20b92,493 crore.<\/strong><\/p>\n Here’s how Hindustan Unilever’s various segments fared during the quarter:<\/strong><\/em><\/p>\n Home care<\/strong>\u00a0business saw revenue of \u20b95,815 crore from \u20b95,709 crore last year.<\/p>\n Beauty & Wellbeing<\/strong>\u00a0business revenue stood at \u20b93,265 crore from \u20b93,062 crore last year.<\/p>\n Personal Care<\/strong>\u00a0revenue stood nearly flat at \u20b92,126 crore from \u20b92,063 crore last year.<\/p>\n Foods<\/strong>\u00a0business revenue stood at \u20b93,896 crore, nearly the same as last year’s figure of \u20b93,910 crore.<\/p>\n The company’s board has also approved a final dividend of \u20b924 per share, taking the full year payout to shareholders to \u20b953 per share. The company’s has not shared any record date for the said dividend yet.<\/strong> <\/p>\n
\nOvernight, Wall Street indices ended higher. Asian stocks were trading in a tight range in early trade today.<\/strong><\/p>\nHype Around Obesity Drugs May Not Mean Gains For Indian Pharma: InCred<\/strong><\/em><\/h6>\n
HUL Q4 Results: Numbers meet expectations; Board approves dividend of \u20b924 per share: But HUL shares decline by 4 %<\/h4>\n
HUL’s Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) increased by 1% during the March quarter to \u20b93,466 crore. The figure is marginally lower with the consensus estimates of analysts, which pegged the figure to be \u20b93,505 crore.<\/strong><\/em><\/h6>\n
\nThe company’s EBITDA margin stood at 22.8%, in comparison to 23% last year. The CNBC-TV18 poll had pegged the figure at 23.1%.<\/strong><\/p>\n
\nShares of Hindustan Unilever are trading 1.4% higher post the results announcement at \u20b92,455.<\/strong><\/p>\n